Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Appendix 1.

Embargoed until 7:00AM 16 December 2005
United Business Media
Pre-close Season Update*
2005 Second Half Trading
TRADING PERFORMANCE IN LINE WITH EXPECTATIONS: EVENTS AND PRN
PERFORMING WELL
GROUP SUMMARY
UBM has continued to achieve profitable underlying revenue growth in its exhibitions, online and news distribution businesses, although in common with the Industry, print remains challenged. Our strategy to increase UBM’s presence in online and exhibitions continues, through acquisitions, disposals and organic initiatives. Acquisitions made in 2004 and 2005 continue to achieve their targeted returns.
Overall trading performance is in line with expectations. PRN and CMP Asia continue to achieve good growth. CMP Medica is performing in line with its business case. CMP Information’s exhibitions are strong, however it has experienced revenue pressure in print. CMP Media is performing in line with expectations overall: events are growing and online growth is strong, offsetting continuing declines in print.
OPERATING HIGHLIGHTS OF THE SECOND HALF OF 2005
CMPI
CMP Information is performing in line with expectations, with strong results in its exhibitions business. In the UK, print revenues have weakened in certain areas, in particular, around recruitment. We have continued to make acquisitions and disposals. In the second half we sold Exchange & Mart and Auto Exchange for £50.2m. We have made acquisitions totalling £51.7m for the year, including the Publican titles and events, ABI Building Data, Informex chemicals show and the Mondial properties “Theme” magazine and “Bar” exhibition.
CMP ASIA
The strong performance of our Asian exhibitions business has continued in the second half, with successful events including the Hong Kong Jewellery & Watch Fair and the All China Leather Exhibition in Shanghai, in September. We continue to explore opportunities for expansion through acquisitions, such as Tissue World and the Japan Jewellery Fair, and through brand extensions and new product launches.
CMPMEDICA
CMPMedica’s performance overall is in line with expectations. The performance of the important French business reflects the good progress made on integrating the French medical trade press and marketing services acquisition. Market conditions have been more challenging in Asia Pacific, particularly for Trade Press, but cost savings have offset any revenue shortfalls.
CMP MEDIA
CMP Media is performing in line with expectations with revenue in H2 broadly flat. Growth in exhibitions and online is offset by declines in print. In Healthcare, CME’s events revenues have largely recovered following changes in the regulatory environment for pharmaceutical companies. Revenue in the US Entertainment business is flat, in line with our expectations. During the second half we have acquired Tech-Online, Light Reading, ICMI and Black Hat for £27.3m, which strengthen CMP’s position in events and online.
PR NEWSWIRE
PR Newswire continues to achieve increases in message volumes, length and yield whilst further expanding its product offering and providing additional services to members; the business is therefore growing in line with expectations. Outside the US, PR Newswire is on track to exceed its 10% margin target.
OPERATING EFFICIENCIES
UBM is continuing its programme of offshoring and outsourcing – this is delivering cost savings and quality improvements.
INVESTMENTS
In the second half we have disposed of a number of the remaining television assets. Our investment in Five was sold to RTL for £247.6m and we have disposed of SIS for £23m.
Total disposals year to date are in excess of £730m.
The acquisitions made in 2004 (£192m) and 2005 year to date (£106m) are performing well and are on track to generate the returns targeted.
ONE OFF ITEMS
The disposals made in 2005 have given rise to significant one-off profits for the year of around £400m. During 2005, following the disposals, we have also undertaken a number of restructuring and business reorganisation projects across several of our continuing businesses. These projects take account of the consequences of the sale of some businesses (principally NOP and Exchange and Mart), the geographic realignment of our publishing divisions and a number of other restructuring actions across the divisions to achieve greater customer and product focus whilst delivering lower operating costs. The costs of these projects will be reported as a one-off item for the year ended 31 December 2005 and will be around £40m for the full year.
FINANCING
During the second half we have continued to return capital; in total £550m has been returned in the year to date. We have now repurchased and cancelled all except $5.7m of the US$250m 7.75% bond due 2009. We have also repurchased and cancelled over 55% of the $400m 2.375% Convertible Bonds due 2006.
CMPMEDICA ANNOUNCEMENT
Following the acquisition and integration of CMPMedica, Stephen Warshaw has decided to leave his post as CEO of CMPMedica and he will stand down next April to pursue new career opportunities. We are pleased that Stephen will be helping with the transition in a consultancy capacity after his departure. UBM has appointed Egon Zehnder to search for a new CEO for CMPMedica.
|
*UBM is scheduled to announce its preliminary results for 2005 on 28 February 2006. This announcement is the routine update prior to entering the January and February close season associated with the preliminary results |
For further information please contact:
For United Business Media enquiries:
Catherine Southgate United Business Media + 44 20 7921 5031
Chris Barrie Citigate Dewe Rogerson + 44 207 282 2943
This press release includes statements which are not historical facts and are considered “forward-looking” within the meaning of Section 27 of the Securities Act of 1933, as amended. These forward-looking statements reflect UBM’s current views about future events, business and growth strategy and financial performance. These forward-looking statements are identified by their use of terms and phrases such as “believe,” “expect,” “plan,” “anticipate,” “on target” and similar expressions identifying forward-looking statements. Investors should not rely on forward-looking statements because they are subject to a variety of risks, uncertainties and other factors that could cause actual results to differ materially from UBM’s expectations. UBM expressly does not undertake any duty to update forward-looking statements. Management does not attempt to update forecasts unless conditions materially change.
Appendix 2.
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
All relevant boxes should be completed in block capital letters.
1. | Name of company |
| |
| UNITED BUSINESS MEDIA PLC |
| |
2. | Name of shareholder having a major interest |
| |
| AXA S.A. and its group companies |
| |
3. | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person’s spouse or children under the age of 18 |
| |
| NON BENEFICIAL ��� See 2 Above |
| And BENEFICIAL |
| |
4. | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them |
| |
| As 2 Above – see attached sheet. |
| |
5. | Number of shares acquired |
| |
| N/A |
| |
6. | Percentage of issued class |
| |
| N/A |
| |
7. | Number of shares/amount of stock disposed |
| |
| N/A |
| |
8. | Percentage of issued class |
| |
| N/A |
| |
9. | Class of security |
| |
| ORDINARY SHARES OF 305/14P |
| |
10. | Date of transaction |
| |
| UNKNOWN |
| |
11. | Date company informed |
| |
| 23 DECEMBER 2005 |
| |
12. | Total holding following this notification |
| |
| 9,763,464 ORDINARY SHARES OF 305/14P |
| |
13. | Total percentage holding of issued class following this notification |
| |
| 3.51% |
| |
14. | Any additional information |
| |
| N/A |
| |
15. | Name of contact and telephone number for queries |
| |
| HELEN MARTIN 020 7921 5062 |
16. | Name and signature of authorised company official responsible for making this notification |
| |
| ANNE SIDDELL |
| COMPANY SECRETARY |
| |
Date of notification: 23 December 2005 |
Registered Holder | | Name of Company/Fund | | No. of Shares | |
| |
| |
| |
HSBC Global Custody Nominee (UK) Limited A/C 867396 | | Sun Life Pensions Management Ltd | | 1530782 | |
HSBC Global Custody Nominee (UK) Limited A/C 867530 | | Sun Life Pensions Management Ltd | | 255294 | |
HSBC Global Custody Nominee (UK) Limited A/C 867372 | | Sun Life Pensions Management Ltd | | 2900000 | |
HSBC Global Custody Nominee (UK) Limited A/C 776934 | | Sun Life Assurance Society plc | | 500000 | |
HSBC Global Custody Nominee (UK) Limited A/C 867116 | | Sun Life Unit Assurance Ltd | | 1400000 | |
HSBC Global Custody Nominee (UK) Limited A/C 867268 | | Sun Life Unit Assurance Ltd | | 379946 | |
HSBC Global Custody Nominee (UK) Limited A/C 887050 | | Sun Life Unit Assurance Ltd | | 250000 | |
Smith and Williamson Nominees Limited A/C S66 | | Sun Life Pensions Management Limited | | 9469 | |
BNY (OCS) Nominees Limited | | Sun Life Pensions Management Limited | | 8455 | |
| | AXA France | | 7661 | |
| | AXA Sun Life plc | | 700000 | |
HSBC Global Custody Nominee (UK) Limited A/C 880868 | | AXA General Unit Trust | | 252883 | |
Chase Nominees Ltd A/C 00994 | | AXA UK Group Pension Scheme Equity Fund | | 802424 | |
HSBC Global Custody Nominee (UK) Limited | | Framlington HSBC | | 21520 | |
| | Alliance Capital Management LP | | 11658 | |
| | TOTAL | | 12,948,390 | |
| | | | | |
|
|
|
|
|
|